<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urovest</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник урологии</journal-title><trans-title-group xml:lang="en"><trans-title>Urology Herald</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2308-6424</issn><publisher><publisher-name>Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2308-6424-2020-8-3-85-96</article-id><article-id custom-type="elpub" pub-id-type="custom">urovest-368</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Влияет ли ботулинотерапия на микробиом мочи больных нейрогенным мочевым пузырём? Результаты метагеномного секвенирования</article-title><trans-title-group xml:lang="en"><trans-title>Does botulinum therapy affect the urine microbiome of patients with neurogenic bladder? Metagenomic sequencing results</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3065-3953</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Филиппова</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Philippova</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Екатерина Сергеевна Филиппова ‒ кандидат медицинских наук; доцент кафедры урологии УрГМУ; врач-уролог свердловской областной клинической больницы №1</p><p>620028, Екатеринбург, ул. Репина, д. 3; 620102, Екатеринбург, ул. Волгоградская, д. 185, тел.: +7 (912) 638-02-86</p></bio><bio xml:lang="en"><p>Ekaterina S. Philippova - M.D., Cand.Sc. (M); Assist. Prof., Dept. of Urology, Ural SMU; Urologist, Urological Division No.3, Sverdlovsk RH No.1.</p><p>620028, Yekaterinburg, 3 Repina str.; 620102, Yekaterinburg, 185 Volgogradskaya str. ; tel.: +7 (912) 638-02-86</p></bio><email xlink:type="simple">filippova.cat@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1745-700X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баженов</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bazhenov</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Игорь Владимирович Баженов - доктор медицинских наук, профессор; профессор кафедры урологии УрГМУ; заведующий 3 урологическим отделением Свердловской ОКБ № 1.</p><p>620028, Екатеринбург, ул. Репина, д. 3; 620102, Екатеринбург, ул. Волгоградская, д. 185</p></bio><bio xml:lang="en"><p>Igor V. Bazhenov - M.D. Dr. Sc. (M), Full Prof.; Prof., Dept. of Urology, Ural SMU; Head, Urological Division No.3, Sverdlovsk RH No.1.</p><p>620028, Yekaterinburg, 3 Repina str.; 620102, Yekaterinburg, 185 Volgogradskaya str.</p></bio><email xlink:type="simple">biv@okb1.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8105-7233</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зырянов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zyrianov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александр Владимирович Зырянов - доктор медицинских наук, профессор; заведующий кафедрой урологии УрГМУ; руководитель Областного урологического центра Свердловской ОКБ №1.</p><p>620028, Екатеринбург, ул. Репина, д. 3; 620102, Екатеринбург, ул. Волгоградская, д. 185</p></bio><bio xml:lang="en"><p>Alexander V. Ziryanov - M.D. Dr. Sc. (M), Full Prof.; Head, Dept. of Urology, Ural SMU; Head, Regional Urological Center, Sverdlovsk RH No.1.</p><p>620028, Yekaterinburg, 3 Repina str.; 620102, Yekaterinburg, 185 Volgogradskaya str.</p></bio><email xlink:type="simple">zav1965@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России; ГБУЗ СО Свердловская областная клиническая больница №1</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ural State Medical University; Sverdlovsk Regional Clinical Hospital No.1</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>04</day><month>10</month><year>2020</year></pub-date><volume>8</volume><issue>3</issue><fpage>85</fpage><lpage>96</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Филиппова Е.С., Баженов И.В., Зырянов А.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Филиппова Е.С., Баженов И.В., Зырянов А.В.</copyright-holder><copyright-holder xml:lang="en">Philippova E.S., Bazhenov I.V., Zyrianov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.urovest.ru/jour/article/view/368">https://www.urovest.ru/jour/article/view/368</self-uri><abstract><sec><title>Введение</title><p>Введение. Реорганизация микробиома мочи больных нейрогенным мочевым пузырем играет важную роль в патогенезе инфекции мочевыводящих путей (ИМп). сведения о составе мочевого микробиома при нейрогенной дисфункции нижних мочевыводящих путей (НДНМп) ограничены, в частности, неизвестно, как на него влияют различные виды терапии НДНМп.</p></sec><sec><title>Цель исследования</title><p>Цель исследования. Оценить влияние инъекций ботулинического токсина на микробиом мочи больных НДНМп.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Образцы мочи были взяты у шести пациентов с НДНМп (четырёх женщин и двух мужчин) до введения 200 ЕД ботулинического токсина типа А в стенку мочевого пузыря и через 6 недель после. Образцы исследовали методом микроскопии, выполняли посев на микробиологические среды, а также метагеномное 16S рРНК секвенирование. с использованием платформы IlluminaMiSeq получено, в общей сложности, 144 562 16S рДНК прочтений.</p></sec><sec><title>Результаты</title><p>Результаты. Результаты посевов мочи коррелировали с данными 16S рРНК секвенирования, однако анализ метагенома позволил выявить и идентифицировать большее количество микроорганизмов. В каждом образце выделено от 2 до 21 рода микроорганизмов. В моче всех больных до ботулинотерапии преобладали Enterobacterales. после ботулинотерапии у трех пациенток, на фоне клинического и уродинамического улучшения, произошла смена микрофлоры с преобладанием Enterobacterales на Lactobacillales. В остальных случаях принципиальных изменений микробиома отмечено не было.</p></sec><sec><title>Заключение</title><p>Заключение. Впервые в рамках пилотного исследование проведено сравнение микробиома мочи у больных НДНМп до и после введения ботулинического токсина. Небольшое число участников является существенным ограничением данной работы, однако продемонстрирована возможность положительного влияния ботулинотерапии на микрофлору мочевыводящих путей.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Reorganization of the urinary microbiome in patients with neurogenic low urinary tract dysfunction (NLUTD) plays an important role in the pathogenesis of urinary tract infections (UTIs). However, we still do not know how the different types of NULTD therapy affect the microbiome.</p></sec><sec><title>Purpose of the study</title><p>Purpose of the study. Was to assess the influence of botulinum toxin (BoNT) injections on the urinary microbiome.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Urine samples were obtained from 6 persons (4 females and 2 males) with NLUTD before BoNT therapy (200 UI) and 6 weeks after. Standard urine analysis, urine culture and 16S rRNA gene sequencing were performed. a total of 144,562 quality-filtered 16S rDNA sequence reads were processed through an Illumina MiSeq platform.</p></sec><sec><title>Results</title><p>Results. The results of the urine culture correlated with 16S rRNA sequencing results, but the greater number of bacterial taxa were detected. Analysis of the bacterial community in urine samples revealed between 2 and 21 species-level reads per individual. All patients before BoNT demonstrated abnormal urinary microbiome with a predominance of Enterobacteriales. In three cases in females, clinical and urodynamic improvement after botulinum therapy was associated with changing of the microbiome from Enterobacteriaceae to Lactobacillales. In one female and two males, no principal changes had happened.</p></sec><sec><title>Conclusions</title><p>Conclusions. This is the first report comparing in pilot study the urinary microbiome before and after BoNT injections into the bladder wall. The results are restricted by the small number of participants. However, the promising observation about the influence of botulinum toxin therapy on urinary microbiome was obtained.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>нейрогенный мочевой пузырь</kwd><kwd>инфекция мочевыводящих путей</kwd><kwd>микробиом мочи</kwd><kwd>ботулинический токсин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>neurogenic bladder</kwd><kwd>urinary tract infection</kwd><kwd>urinary microbiome</kwd><kwd>botulinum toxin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Nelson DE, Van Der pol B, Dong Q, Revanna KV, Fan B, Easwaran S, Sodergren E, Weinstock GM, Diao L, Fortenberry JD. Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLoS One. 2010;5(11):e14116. https://doi.org/10.1371/journal.pone.0014116</mixed-citation><mixed-citation xml:lang="en">Nelson DE, Van Der pol B, Dong Q, Revanna KV, Fan B, Easwaran S, Sodergren E, Weinstock GM, Diao L, Fortenberry JD. Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLoS One. 2010;5(11):e14116. https://doi.org/10.1371/journal.pone.0014116</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Набока Ю.Л., Гудима И.А., Коган М.И., Черницкая М.Л. Микробный спектр мочи молодых здоровых женщин. Урология. 2010;(5):7-10. eLIBRARY ID: 15242297</mixed-citation><mixed-citation xml:lang="en">Naboka Yu.L., Gudima I.A., Kogan M.I., Chernitskaya M.L. Bacterial spectrum of the urine in young healthy women. Urologiia. 2010;(5):7-10. (In Russ.). eLIBRARY ID: 15242297</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakobsen KS. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol. 2011;11:244. https://doi.org/10.1186/1471-2180-11-244</mixed-citation><mixed-citation xml:lang="en">Siddiqui H, Nederbragt AJ, Lagesen K, Jeansson SL, Jakobsen KS. Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol. 2011;11:244.	https://doi.org/10.1186/1471-2180-11-244</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dong Q, Nelson DE, Toh E, Diao L, Gao X, Fortenberry JD, Van der Pol B. The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS One. 2011;6(5):e19709. https://doi.org/10.1371/journal.pone.0019709</mixed-citation><mixed-citation xml:lang="en">Dong Q, Nelson DE, Toh E, Diao L, Gao X, Fortenberry JD, Van der Pol B. The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS One. 2011;6(5):e19709. https://doi.org/10.1371/journal.pone.0019709</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ, Huang ST, Ljungberg I, Sprague BM, Lucas SK, Torralba M, Nelson KE, Groah SL. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med. 2012;10:174. https://doi.org/10.1186/1479-5876-10-174</mixed-citation><mixed-citation xml:lang="en">Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ, Huang ST, Ljungberg I, Sprague BM, Lucas SK, Torralba M, Nelson KE, Groah SL. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med. 2012;10:174. https://doi.org/10.1186/1479-5876-10-174</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, Mueller ER, Schreckenberger P, Dong Q, Nelson DE, Brubaker L. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50(4):1376-1383. https://doi.org/10.1128/JCM.05852-11</mixed-citation><mixed-citation xml:lang="en">Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, Mueller ER, Schreckenberger P, Dong Q, Nelson DE, Brubaker L. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50(4):1376-1383. https://doi.org/10.1128/JCM.05852-11</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis DA, Brown R, Williams J, White P, Jacobson SK, Mar-chesi JR, Drake MJ. The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol. 2013;3:41. https://doi.org/10.3389/fcimb.2013.00041</mixed-citation><mixed-citation xml:lang="en">Lewis DA, Brown R, Williams J, White P, Jacobson SK, Mar-chesi JR, Drake MJ. The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol. 2013;3:41. https://doi.org/10.3389/fcimb.2013.00041</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Коган М.И., Набока Ю.Л., Ибишев Х.С., Гудима И.А. Нестерильность мочи здорового человека — новая парадигма в медицине. Урология. 2014;(5):48-52. eLIBRARY ID: 22809344</mixed-citation><mixed-citation xml:lang="en">Kogan M.I., Naboka Yu.L., Ibishev Kh.S., Gudima I.A. Unsterile urine in health human — new paradigm in medicine. Urologiia.2014;(5):48-52. (In Russ.). eLIBRARY ID: 22809344</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Groah SL, Perez-Losada M, Caldovic L, Ljungberg IH, Sprague BM, castro-Nallar E, chandel NJ, Hsieh MH, Pohl HG. Redefining Healthy Urine: A Cross-Sectional Exploratory Metagenomic Study of People With and Without Bladder Dysfunction. J Urol. 2016;196(2):579-587. https://doi.org/10.1016/j.juro.2016.01.088</mixed-citation><mixed-citation xml:lang="en">Groah SL, Perez-Losada M, Caldovic L, Ljungberg IH, Sprague BM, Castro-Nallar E, Chandel NJ, Hsieh MH, Pohl HG. Redefining Healthy Urine: A Cross-Sectional Exploratory Metagenomic Study of People With and Without Bladder Dysfunction. J Urol. 2016;196(2):579-587. https://doi.org/10.1016/j.juro.2016.01.088</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Karstens L, Asquith M, Davin S, Stauffer P, Fair D, Gregory WT, Rosenbaum JT, McWeeney SK, Nardos R. Does the Urinary Microbiome Play a Role in Urgency Urinary Incontinence and Its Severity? Front Cell Infect Microbiol. 2016;6:78. https://doi.org/10.3389/fcimb.2016.00078</mixed-citation><mixed-citation xml:lang="en">Karstens L, Asquith M, Davin S, Stauffer P, Fair D, Gregory WT, Rosenbaum JT, McWeeney SK, Nardos R. Does the Urinary Microbiome Play a Role in Urgency Urinary Incontinence and Its Severity? Front Cell Infect Microbiol. 2016;6:78. https://doi.org/10.3389/fcimb.2016.00078</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, Kliethermes S, Schreckenberger PC, Brubaker L, Gai X, Wolfe AJ. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5(4):e01283-14. https://doi.org/10.1128/mBio.01283-14</mixed-citation><mixed-citation xml:lang="en">Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, Kliethermes S, Schreckenberger PC, Brubaker L, Gai X, Wolfe AJ. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5(4):e01283-14. https://doi.org/10.1128/mBio.01283-14</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Govender Y, Gabriel I, Minassian V, Fichorova R. The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women. Front Cell Infect Microbiol. 2019;9:133. https://doi.org/10.3389/fcimb.2019.00133</mixed-citation><mixed-citation xml:lang="en">Govender Y, Gabriel I, Minassian V, Fichorova R. The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women. Front Cell Infect Microbiol. 2019;9:133. https://doi.org/10.3389/fcimb.2019.00133</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Коган М.И., Набока Ю.Л., Исмаилов Р.С. Микробиота секрета простаты: сравнительный анализ хронического простатита категорий II и IIIA. Урология. 2020;(2):16-22. https://dx.doi.org/10.18565/urology.2020.2.16-22</mixed-citation><mixed-citation xml:lang="en">Kogan M.I., Naboka Y.L., Ismailov R.S. Prostatic secretion microbiota: a comparative analysis of the сhromcal prostatitis II and IIIA category. Urologiia. 2020;(2):16-22. (In Russ.). https://dx.doi.org/10.18565/urology.2020.2.16-22</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Meriwether KV, Lei Z, Singh R, Gaskins J, Hobson DTG, Jala V. The Vaginal and Urinary Microbiomes in Premenopausal Women With Interstitial Cystitis/Bladder Pain Syndrome as Compared to Unaffected Controls: A Pilot Cross-Sectional Study. Front Cell Infect Microbiol. 2019;9:92. https://doi.org/10.3389/fcimb.2019.00092</mixed-citation><mixed-citation xml:lang="en">Meriwether KV, Lei Z, Singh R, Gaskins J, Hobson DTG, Jala V. The Vaginal and Urinary Microbiomes in Premenopausal Women With Interstitial Cystitis/Bladder Pain Syndrome as Compared to Unaffected Controls: A Pilot Cross-Sectional Study. Front Cell Infect Microbiol. 2019;9:92. https://doi.org/10.3389/fcimb.2019.00092</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Abernethy MG, Rosenfeld A, White JR, Mueller MG, Le-wicky-Gaupp C, Kenton K. Urinary Microbiome and Cytokine Levels in Women With Interstitial Cystitis. Obstet Gynecol. 2017;129(3):500-506. https://doi.org/10.1097/AOG.0000000000001892</mixed-citation><mixed-citation xml:lang="en">Abernethy MG, Rosenfeld A, White JR, Mueller MG, Le-wicky-Gaupp C, Kenton K. Urinary Microbiome and Cytokine Levels in Women With Interstitial Cystitis. Obstet Gynecol. 2017;129(3):500-506. https://doi.org/10.1097/AOG.0000000000001892</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bucević Popović V, Situm M, Chow CT, Chan LS, Roje B, Terzić J. The urinary microbiome associated with bladder cancer. Sci Rep. 2018;8(1):12157. https://doi.org/10.1038/s41598-018-29054-w</mixed-citation><mixed-citation xml:lang="en">Bucević Popović V, Situm M, Chow CT, Chan LS, Roje B, Terzić J. The urinary microbiome associated with bladder cancer. Sci Rep. 2018;8(1):12157. https://doi.org/10.1038/s41598-018-29054-w</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Wu P, Zhang G, Zhao J, Chen J, Chen Y, Huang W, Zhong J, Zeng J. Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China. Front Cell Infect Microbiol. 2018;8:167. https://doi.org/10.3389/fcimb.2018.00167 Erratum in: Front Cell Infect Microbiol. 2018;8:429. PMID: 29904624.</mixed-citation><mixed-citation xml:lang="en">Wu P, Zhang G, Zhao J, Chen J, Chen Y, Huang W, Zhong J, Zeng J. Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China. Front Cell Infect Microbiol. 2018;8:167.	https://doi.org/10.3389/fcimb.2018.00167 Erratum in: Front Cell Infect Microbiol. 2018;8:429. PMID: 29904624.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kirmusaoglu S, Yurdugul S, Metin A, Vehid S. The Effect of Urinary Catheters on Microbial Biofilms and Catheter Associated Urinary Tract Infections. Urol J. 2017;14(2):3028-3034. PMID: 28299769.</mixed-citation><mixed-citation xml:lang="en">Kirmusaoglu S, Yurdugul S, Metin A, Vehid S. The Effect of Urinary Catheters on Microbial Biofilms and Catheter Associated Urinary Tract Infections. Urol J. 2017;14(2):3028-3034. PMID: 28299769.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mehta M, Goldfarb DS, Nazzal L. The role of the microbiome in kidney stone formation. Int J Surg. 2016;36(Pt D):607-612. https://doi.org/10.1016/j.ijsu.2016.11.024</mixed-citation><mixed-citation xml:lang="en">Mehta M, Goldfarb DS, Nazzal L. The role of the microbiome in kidney stone formation. Int J Surg. 2016;36(Pt D):607-612. https://doi.org/10.1016/j.ijsu.2016.11.024</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Tornic J, Wollner J, Leitner L, Mehnert U, Bachmann LM, Kessler TM. The Challenge of Asymptomatic Bacte-riuria and Symptomatic Urinary Tract Infections in Patients with Neurogenic Lower Urinary Tract Dysfunction. J Urol. 2020;203(3):579-584. https://doi.org/10.1097/JU.0000000000000555</mixed-citation><mixed-citation xml:lang="en">Tornic J, Wollner J, Leitner L, Mehnert U, Bachmann LM, Kessler TM. The Challenge of Asymptomatic Bacte-riuria and Symptomatic Urinary Tract Infections in Patients with Neurogenic Lower Urinary Tract Dysfunction. J Urol. 2020;203(3):579-584.	https://doi.org/10.1097/JU.0000000000000555</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med. 2002;113 Suppl 1A:67S-79S. https://doi.org/10.1016/s0002-9343(02)01061-6</mixed-citation><mixed-citation xml:lang="en">Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med. 2002;113 Suppl 1A:67S-79S. https://doi.org/10.1016/s0002-9343(02)01061-6</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sung BM, Oh DJ, Choi MH, Choi HM. Chronic kidney disease in neurogenic bladder. Nephrology (Carlton). 2018;23(3):231-236. https://doi.org/10.1111/nep.12990</mixed-citation><mixed-citation xml:lang="en">Sung BM, Oh DJ, Choi MH, Choi HM. Chronic kidney disease in neurogenic bladder. Nephrology (Carlton). 2018;23(3):231-236. https://doi.org/10.1111/nep.12990</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol. 2016;5(1):72-87. https://doi.org/10.3978Zj.issn.2223-4683.2016.01.06</mixed-citation><mixed-citation xml:lang="en">Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol. 2016;5(1):72-87. https://doi.org/10.3978/j.issn.2223-4683.2016.01.06</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Linsenmeyer TA. Catheter-associated urinary tract infections in persons with neurogenic bladders. J Spinal Cord Med. 2018;41(2):132-141. https://doi.org/10.1080/10790268.2 017.1415419</mixed-citation><mixed-citation xml:lang="en">Linsenmeyer TA. Catheter-associated urinary tract infections in persons with neurogenic bladders. J Spinal Cord Med. 2018;41(2):132-141. https://doi.org/10.1080/10790268.2017.1415419</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Pichler M, Coskun OK, Ortega-Arbulu AS, Conci N, Worhe-ide G, Vargas S, Orsi WD. A 16S rRNA gene sequencing and analysis protocol for the Illumina MiniSeq platform. Micro-biologyopen. 2018;7(6):e00611. https://doi.org/10.1002/mbo3.611</mixed-citation><mixed-citation xml:lang="en">Pichler M, Coskun OK, Ortega-Arbulu AS, Conci N, Worhe-ide G, Vargas S, Orsi WD. A 16S rRNA gene sequencing and analysis protocol for the Illumina MiniSeq platform. Micro-biologyopen. 2018;7(6):e00611. https://doi.org/10.1002/mbo3.611</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Microbiome Utilities Portal of the Broad Institute. Доступно по: http://microbiomeutil.sourceforge.net/ Ссылка активна на 03.04.2020.</mixed-citation><mixed-citation xml:lang="en">Microbiome Utilities Portal of the Broad Institute. Available at: http://microbiomeutil.sourceforge.net/ Accessed April 3, 2020.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Game X, Castel-Lacanal E, Bentaleb Y, Thiry-Escudie I, De Boissezon X, Malavaud B, Marque P, Rischmann P. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol. 2008;53(3):613-618. https://doi.org/10.1016/j.euru-ro.2007.08.039</mixed-citation><mixed-citation xml:lang="en">Game X, Castel-Lacanal E, Bentaleb Y, Thiry-Escudie I, De Boissezon X, Malavaud B, Marque P, Rischmann P. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol. 2008;53(3):613-618. https://doi.org/10.1016/j.euru-ro.2007.08.039</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Bank S, Hansen TM, S0by KM, Lund L, Prag J. Actinobacu-lum schaalii in urological patients, screened with realtime polymerase chain reaction. Scand J Urol Nephrol. 2011;45(6):406-410. https://doi.org/10.3109/00365599.2011.599333</mixed-citation><mixed-citation xml:lang="en">Bank S, Hansen TM, S0by KM, Lund L, Prag J. Actinobaculum schaalii in urological patients, screened with realtime polymerase chain reaction. Scand J Urol Nephrol. 2011;45(6):406-410. https://doi.org/10.3109/00365599.2011.599333</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lee JW, Shim YH, Lee SJ. Lactobacillus colonization status in infants with urinary tract infection. Pediatr Nephrol. 2009;24(1):135-139. https://doi.org/10.1007/s00467-008-0974-z</mixed-citation><mixed-citation xml:lang="en">Lee JW, Shim YH, Lee SJ. Lactobacillus colonization status in infants with urinary tract infection. Pediatr Nephrol. 2009;24(1):135-139. https://doi.org/10.1007/s00467-008-0974-z</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, Intermittent Self-Catheterization in the Treatment of Urinary Tract Disease. J Urol. 2017;197(2S):S122-S124. https://doi.org/10.1016/j.juro.2016.10.097</mixed-citation><mixed-citation xml:lang="en">Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, Intermittent Self-Catheterization in the Treatment of Urinary Tract Disease. J Urol. 2017;197(2S):S122-S124. https://doi.org/10.1016/j.juro.2016.10.097</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Lapides J, Diokno АС, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol. 1972;107(3):458-461. https://doi.org/10.1016/s0022-5347(17)61055-3</mixed-citation><mixed-citation xml:lang="en">Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol.	1972;107(3):458-461. https://doi.org/10.1016/s0022-5347(17)61055-3</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn. 2014;33(1):95-100. https://doi.org/10.1002/nau.22378</mixed-citation><mixed-citation xml:lang="en">Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn. 2014;33(1):95-100. https://doi.org/10.1002/nau.22378</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Набока Ю.Л., Коган М.И., Гудима И.А., Заруцкий С.А., Джалагония К.Т. Есть ли дневные вариации микробиоты мочи у здоровых женщин? Нефрология. 2016;20(5):36-42. eLIBRARY ID: 26727702.</mixed-citation><mixed-citation xml:lang="en">Naboka Yu.L., Kogan M.I., Gudima I.A., Zarutskiy S.A., Jala-gonia K.T. Does the urine microbiota of healthy women vary during daytime? Nephrology. 2016;20(5):36-42. (In Russ.). eLIBRARY ID: 26727702.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
